Experiences with cogentin in the treatment of Parkinsonism. A one-year controlled study of 94 patients.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009966:Orphenadrine / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D014326:Tropanes / Q000009:adverse effects / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D014326:Tropanes; D009966:Orphenadrine